COMPARISON OF THE EFFECTS OF ORAL DEFERIPRONE AND SUBCUTANEOUS DEFEROXAMINE ON VENTRICULAR EFECTION FRACTION IN BETA-THALASSEMIA MAJOR PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

RAEISI N.; RAEISI P.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S) Year:2006 | Volume:24 | Issue:82 (SUPPLEMENT) Page(s): 44-48

Download Full-Text

Persian Verion

View:

1,139

Download:

Cites:

Information Journal Paper

Title

COMPARISON OF THE EFFECTS OF ORAL DEFERIPRONE AND SUBCUTANEOUS DEFEROXAMINE ON VENTRICULAR EFECTION FRACTION IN BETA-THALASSEMIA MAJOR PATIENTS

Author(s)

RAEISI N. | RAEISI P. | Issue Writer Certificate

Keywords

DEFERIPRONEQ3

DEFEROXAMINEQ3

CHELATIONQ3

EJECTION FRACTIONQ3

THALASSEMIA MAJORQ3

Abstract

Introduction: Cardiac disease due to iron overload remains the main cause of death in beta-thalassemia major (TM). Successful iron CHELATION is therefore essential for the optimal management of thalassemia. DEFEROXAMINE (DFO) is still the first-line chelating agent in these patients, but compliance is a major hindrance to achieving optimal therapeutic results. Some studies have suggested that DEFERIPRONE (L1), an orally active chelating drug, provides superior cardioprotection compared to DEFEROXAMINE. The minimum time for this effect is over 6 months. We compared L1 with DFO, in beta-thalassemia major patients for cardioprotection during a one-yare period.Methods: A prospective clinical study was performed on 48 patients assigned to two equal groups. Group 1 patients only received DEFERIPRONE and group 2 patients received DEFEROXAMINE. We compared serum ferritin and left ventricular EJECTION FRACTION (LVEE) of the two groups after one year.Results: Left ventricular EJECTION FRACTION and serum ferritin were not significantly different between the two groups at the end of study (mean LVEE±SD: 62.5±5.5 in group 1, 61.2±5.8 in group 2, P=0.43; mean serum ferritin±SD: 2354±1200 ng/cc in group 1, 2284±1244 ng/cc in group2, P=0.92). Transient gastrointestinal symptoms were the most frequent adverse effects in DEFERIPRONEtreated patients and there were no episodes of agranulocytosis.Conclusions: Monotherapy with L1 during a one-year period offered no superior cardioproteetion compared to DFO. Future longitudinal studies with longer follow-ups are warranted.

Cites

No record.

References

No record.

Cite

APA: Copy

RAEISI, N., & RAEISI, P.. (2006). COMPARISON OF THE EFFECTS OF ORAL DEFERIPRONE AND SUBCUTANEOUS DEFEROXAMINE ON VENTRICULAR EFECTION FRACTION IN BETA-THALASSEMIA MAJOR PATIENTS. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 24(82 (SUPPLEMENT)), 44-48. SID. https://sid.ir/paper/404776/en

Vancouver: Copy

RAEISI N., RAEISI P.. COMPARISON OF THE EFFECTS OF ORAL DEFERIPRONE AND SUBCUTANEOUS DEFEROXAMINE ON VENTRICULAR EFECTION FRACTION IN BETA-THALASSEMIA MAJOR PATIENTS. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2006;24(82 (SUPPLEMENT)):44-48. Available from: https://sid.ir/paper/404776/en

IEEE: Copy

N. RAEISI, and P. RAEISI, “COMPARISON OF THE EFFECTS OF ORAL DEFERIPRONE AND SUBCUTANEOUS DEFEROXAMINE ON VENTRICULAR EFECTION FRACTION IN BETA-THALASSEMIA MAJOR PATIENTS,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 24, no. 82 (SUPPLEMENT), pp. 44–48, 2006, [Online]. Available: https://sid.ir/paper/404776/en

Related Journal Papers